Infusion 51a is an impact-focused investment fund on a mission to invest in, develop, and advance world-changing innovation. Initially, it seeks disruptive precision-based opportunities within the life sciences.
INVEST in Passion!
INVEST in Passion!
Infusion 51a is an impact-focused investment fund on a mission to invest in, develop, and advance world-changing innovation. Initially, it seeks disruptive precision-based opportunities within the life sciences.
What is Infusion 51a?
Infusion 51a, nestled in the heart of the US research triangle in North Carolina, is dedicated to fostering the advancement of groundbreaking health solutions worldwide.
Our focus spans a diverse array of transformative companies, ranging from targeted therapeutics to precision diagnostics, from nanotechnology to bioengineering, augmented by artificial intelligence and big data innovations.
With a seasoned team deeply entrenched in the Life Science investment sphere, we specialize in bridging visionary investors with trailblazing entrepreneurs, united by a shared commitment to effecting positive change.
We extend an invitation to visionary founders and investors to join our mission.
What is Infusion 51a?
Infusion 51a, nestled in the heart of the US Research Triangle in North Carolina, is dedicated to fostering the advancement of groundbreaking health solutions worldwide.
Our focus spans a diverse array of transformative companies, ranging from targeted therapeutics to precision diagnostics, from nanotechnology to bioengineering, augmented by artificial intelligence and big data innovations.
With a seasoned team deeply entrenched in the life science investment sphere, we specialize in bridging visionary investors with trailblazing entrepreneurs, united by a shared commitment to effecting positive change.
We extend an invitation to visionary founders and investors to join our mission.
INSPIRE Change!
We seek revolutionary life-science innovation at the forefront of the innovation within healthcare. Our team takes a hands-on approach within our investment management.
We are expanding globally, including our growth within the Middle East and Africa region. We are seeking opportunities to foster innovation and offer a unique opportunity for international investors.
INSPIRE Change!
We seek revolutionary life-science innovation at the forefront of the innovation within healthcare. Our team takes a hands-on approach within our investment management.
We are expanding globally, including our growth within the Middle East and Africa region. We are seeking opportunities to foster innovation and offer a unique opportunity for international investors.
IGNITE the World!
For us, being impact-driven goes beyond investing: our organization doesn’t just elevate life-science by investing. We get involved within the communities we aim to serve.
Together Against Glioblastoma is an Infusion 51a-led private Facebook Group that provides people with a platform where they can share experiences, receive guidance and find educational resources in their fight against the deadliest form of brain cancer.
In Dubai, we launched the #FacesNotNumbers campaign, aimed to shine a light on inspiring stories often hidden behind cancer statistics.
IGNITE the World!
For us, being impact-driven goes beyond investing: our organization doesn’t just elevate life-science by investing. We get involved within the communities we aim to serve.
Together Against Glioblastoma is an Infusion 51a-led private Facebook Group that provides people with a platform where they can share experiences, receive guidance and find educational resources in their fight against the deadliest form of brain cancer.
In Dubai, we launched the #FacesNotNumbers campaign, aimed to shine a light on inspiring stories often hidden behind cancer statistics.
A look into the biotech landscape
The size and variety of the biotech sector make it suitable for almost anyone to build a diversified portfolio. Over the past decade, investors have repeatedly profited from biotech’s limitless potential, with stocks having far outperformed the S&P 500 (Mckinsey, 2022). It‘s never too late to start — why not doing it now?
Biotechnology Global Industry Analysis and Forecast 2022 – 2030 (Precedence Research)
Biotechnology has rapidly improved and changed the landscape of treatment options, with precision medicines using big data, proteomics, transcriptomic, and molecular imaging to create new systemic therapies. These advancements translate into countless opportunities for investors and, ultimately, better outcomes for patients.
Sources: Surgical Oncology Clinics of North America (2021), The Lancet (2021), Frontiers in Genetics (2020), BMC Medical Informatics and Decision Making (2018), International Risk Governance Council (2018)
Sources: Surgical Oncology Clinics of North America (2021), The Lancet (2021), Frontiers in Genetics (2020), BMC Medical Informatics and Decision Making (2018), International Risk Governance Council (2018)